[HTML][HTML] Emerging mechanisms and applications of low-dose IL-2 therapy in autoimmunity

P Zhou - Cytokine & Growth Factor Reviews, 2022 - Elsevier
Abstract Interleukin 2 (IL-2) is a pleiotropic cytokine that elicits both immunogenic and
tolerogenic immune response essential for homeostasis. Initial clinical application of IL-2 …

Therapeutic potential of interleukin-2 in autoimmune diseases

Y Yuan, AGA Kolios, Y Liu, B Zhang, H Li… - Trends in Molecular …, 2022 - cell.com
Autoimmune diseases are characterized by dysregulation and aberrant activation of cells in
the immune system. Therefore, restoration of the immune balance represents a promising …

SARS-CoV-2 infection induces a long-lived pro-inflammatory transcriptional profile

JY Zhang, JP Whalley, JC Knight, LS Wicker, JA Todd… - Genome Medicine, 2023 - Springer
Background The immune response to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection in COVID-19 patients has been extensively investigated. However …

T cell dysregulation in SLE

K Tenbrock, T Rauen - Clinical Immunology, 2022 - Elsevier
T helper cells aid B cells with the production of antibodies and thus play a central role in
disease development of systemic lupus erythematosus (SLE). Numerous T helper cell …

Cytokine-mediated immunomodulation of osteoclastogenesis

P Zhou, T Zheng, B Zhao - Bone, 2022 - Elsevier
Cytokines are an important set of proteins regulating bone homeostasis. In inflammation
induced bone resorption, cytokines, such as RANKL, TNF-α, M-CSF, are indispensable for …

[HTML][HTML] Longitudinal analysis of memory Tfh cells and antibody response following CoronaVac vaccination

P Zhou, C Cao, T Ji, T Zheng, Y Dai, M Liu, J Jiang… - JCI insight, 2023 - ncbi.nlm.nih.gov
The inactivated vaccine CoronaVac is one of the most widely used COVID-19 vaccines
globally. However, the longitudinal evolution of the immune response induced by …

Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes

JY Zhang, F Hamey, D Trzupek, M Mickunas… - Nature …, 2022 - nature.com
Despite early clinical successes, the mechanisms of action of low-dose interleukin-2 (LD-IL-
2) immunotherapy remain only partly understood. Here we examine the effects of interval …

Dilemma of immunosuppression and infection risk in systemic lupus erythematosus

J He, Z Li - Rheumatology, 2023 - academic.oup.com
Patients with SLE are at high risk of various infections as evidenced by a number of studies.
The main determinants of infection in SLE are disease activity, organ damage, and often …

Low-dose IL-2 therapy in autoimmune diseases: an update review

R Zhang, Y Zhao, X Chen, Z Zhuang, X Li… - … Reviews of Immunology, 2024 - Taylor & Francis
Regulatory T (Treg) cells are essential for maintaining self-immune tolerance. Reduced
numbers or functions of Treg cells have been involved in the pathogenesis of various …

Th1-related transcription factors and cytokines in systemic lupus erythematosus

YY Tang, DC Wang, YY Chen, WD Xu… - Frontiers in …, 2023 - frontiersin.org
Systemic lupus erythematosus (SLE) is an inflammatory disorder related to immunity
dysfunction. The Th1 cell family including Th1 cells, transcription factor T-bet, and related …